Global Contrast Agent Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Contrast Agent market report explains the definition, types, applications, major countries, and major players of the Contrast Agent market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Beekley Medical

    • ACIST Medical Systems

    • Medrad

    • AMAG Pharmaceuticals

    • Bayer Healthcare Pharmaceuticals

    • Nova Biomedical

    • Guerbet

    • Bracco Diagnostic

    • Lantheus Medical

    • NycomedAmersham

    • Targeson

    • Daiichi

    • Pinyons Medical Technology

    • Covidien

    • Mallinckrodt Pharmaceuticals

    • GE Healthcare

    By Type:

    • Gadolinium-Based Contrast Media

    • Barium-Based Contrast Media

    • Iodinated Contrast Media

    By End-User:

    • Interventional Cardiology

    • Radiology

    • Interventional Radiology

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Contrast Agent Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Contrast Agent Outlook to 2028- Original Forecasts

    • 2.2 Contrast Agent Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Contrast Agent Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Contrast Agent Market- Recent Developments

    • 6.1 Contrast Agent Market News and Developments

    • 6.2 Contrast Agent Market Deals Landscape

    7 Contrast Agent Raw Materials and Cost Structure Analysis

    • 7.1 Contrast Agent Key Raw Materials

    • 7.2 Contrast Agent Price Trend of Key Raw Materials

    • 7.3 Contrast Agent Key Suppliers of Raw Materials

    • 7.4 Contrast Agent Market Concentration Rate of Raw Materials

    • 7.5 Contrast Agent Cost Structure Analysis

      • 7.5.1 Contrast Agent Raw Materials Analysis

      • 7.5.2 Contrast Agent Labor Cost Analysis

      • 7.5.3 Contrast Agent Manufacturing Expenses Analysis

    8 Global Contrast Agent Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Contrast Agent Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Contrast Agent Export by Region (Top 10 Countries) (2017-2028)

    9 Global Contrast Agent Market Outlook by Types and Applications to 2022

    • 9.1 Global Contrast Agent Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Gadolinium-Based Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Barium-Based Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)

    • 9.2 Global Contrast Agent Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Interventional Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Radiology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Interventional Radiology Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Contrast Agent Market Analysis and Outlook till 2022

    • 10.1 Global Contrast Agent Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Contrast Agent Consumption (2017-2022)

      • 10.2.2 Canada Contrast Agent Consumption (2017-2022)

      • 10.2.3 Mexico Contrast Agent Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Contrast Agent Consumption (2017-2022)

      • 10.3.2 UK Contrast Agent Consumption (2017-2022)

      • 10.3.3 Spain Contrast Agent Consumption (2017-2022)

      • 10.3.4 Belgium Contrast Agent Consumption (2017-2022)

      • 10.3.5 France Contrast Agent Consumption (2017-2022)

      • 10.3.6 Italy Contrast Agent Consumption (2017-2022)

      • 10.3.7 Denmark Contrast Agent Consumption (2017-2022)

      • 10.3.8 Finland Contrast Agent Consumption (2017-2022)

      • 10.3.9 Norway Contrast Agent Consumption (2017-2022)

      • 10.3.10 Sweden Contrast Agent Consumption (2017-2022)

      • 10.3.11 Poland Contrast Agent Consumption (2017-2022)

      • 10.3.12 Russia Contrast Agent Consumption (2017-2022)

      • 10.3.13 Turkey Contrast Agent Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Contrast Agent Consumption (2017-2022)

      • 10.4.2 Japan Contrast Agent Consumption (2017-2022)

      • 10.4.3 India Contrast Agent Consumption (2017-2022)

      • 10.4.4 South Korea Contrast Agent Consumption (2017-2022)

      • 10.4.5 Pakistan Contrast Agent Consumption (2017-2022)

      • 10.4.6 Bangladesh Contrast Agent Consumption (2017-2022)

      • 10.4.7 Indonesia Contrast Agent Consumption (2017-2022)

      • 10.4.8 Thailand Contrast Agent Consumption (2017-2022)

      • 10.4.9 Singapore Contrast Agent Consumption (2017-2022)

      • 10.4.10 Malaysia Contrast Agent Consumption (2017-2022)

      • 10.4.11 Philippines Contrast Agent Consumption (2017-2022)

      • 10.4.12 Vietnam Contrast Agent Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Contrast Agent Consumption (2017-2022)

      • 10.5.2 Colombia Contrast Agent Consumption (2017-2022)

      • 10.5.3 Chile Contrast Agent Consumption (2017-2022)

      • 10.5.4 Argentina Contrast Agent Consumption (2017-2022)

      • 10.5.5 Venezuela Contrast Agent Consumption (2017-2022)

      • 10.5.6 Peru Contrast Agent Consumption (2017-2022)

      • 10.5.7 Puerto Rico Contrast Agent Consumption (2017-2022)

      • 10.5.8 Ecuador Contrast Agent Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Contrast Agent Consumption (2017-2022)

      • 10.6.2 Kuwait Contrast Agent Consumption (2017-2022)

      • 10.6.3 Oman Contrast Agent Consumption (2017-2022)

      • 10.6.4 Qatar Contrast Agent Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Contrast Agent Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Contrast Agent Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Contrast Agent Consumption (2017-2022)

      • 10.7.2 South Africa Contrast Agent Consumption (2017-2022)

      • 10.7.3 Egypt Contrast Agent Consumption (2017-2022)

      • 10.7.4 Algeria Contrast Agent Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Contrast Agent Consumption (2017-2022)

      • 10.8.2 New Zealand Contrast Agent Consumption (2017-2022)

    11 Global Contrast Agent Competitive Analysis

    • 11.1 Beekley Medical

      • 11.1.1 Beekley Medical Company Details

      • 11.1.2 Beekley Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Beekley Medical Contrast Agent Main Business and Markets Served

      • 11.1.4 Beekley Medical Contrast Agent Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 ACIST Medical Systems

      • 11.2.1 ACIST Medical Systems Company Details

      • 11.2.2 ACIST Medical Systems Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 ACIST Medical Systems Contrast Agent Main Business and Markets Served

      • 11.2.4 ACIST Medical Systems Contrast Agent Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Medrad

      • 11.3.1 Medrad Company Details

      • 11.3.2 Medrad Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Medrad Contrast Agent Main Business and Markets Served

      • 11.3.4 Medrad Contrast Agent Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 AMAG Pharmaceuticals

      • 11.4.1 AMAG Pharmaceuticals Company Details

      • 11.4.2 AMAG Pharmaceuticals Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 AMAG Pharmaceuticals Contrast Agent Main Business and Markets Served

      • 11.4.4 AMAG Pharmaceuticals Contrast Agent Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bayer Healthcare Pharmaceuticals

      • 11.5.1 Bayer Healthcare Pharmaceuticals Company Details

      • 11.5.2 Bayer Healthcare Pharmaceuticals Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bayer Healthcare Pharmaceuticals Contrast Agent Main Business and Markets Served

      • 11.5.4 Bayer Healthcare Pharmaceuticals Contrast Agent Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Nova Biomedical

      • 11.6.1 Nova Biomedical Company Details

      • 11.6.2 Nova Biomedical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Nova Biomedical Contrast Agent Main Business and Markets Served

      • 11.6.4 Nova Biomedical Contrast Agent Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Guerbet

      • 11.7.1 Guerbet Company Details

      • 11.7.2 Guerbet Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Guerbet Contrast Agent Main Business and Markets Served

      • 11.7.4 Guerbet Contrast Agent Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Bracco Diagnostic

      • 11.8.1 Bracco Diagnostic Company Details

      • 11.8.2 Bracco Diagnostic Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Bracco Diagnostic Contrast Agent Main Business and Markets Served

      • 11.8.4 Bracco Diagnostic Contrast Agent Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Lantheus Medical

      • 11.9.1 Lantheus Medical Company Details

      • 11.9.2 Lantheus Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Lantheus Medical Contrast Agent Main Business and Markets Served

      • 11.9.4 Lantheus Medical Contrast Agent Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 NycomedAmersham

      • 11.10.1 NycomedAmersham Company Details

      • 11.10.2 NycomedAmersham Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 NycomedAmersham Contrast Agent Main Business and Markets Served

      • 11.10.4 NycomedAmersham Contrast Agent Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Targeson

      • 11.11.1 Targeson Company Details

      • 11.11.2 Targeson Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Targeson Contrast Agent Main Business and Markets Served

      • 11.11.4 Targeson Contrast Agent Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Daiichi

      • 11.12.1 Daiichi Company Details

      • 11.12.2 Daiichi Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Daiichi Contrast Agent Main Business and Markets Served

      • 11.12.4 Daiichi Contrast Agent Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Pinyons Medical Technology

      • 11.13.1 Pinyons Medical Technology Company Details

      • 11.13.2 Pinyons Medical Technology Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Pinyons Medical Technology Contrast Agent Main Business and Markets Served

      • 11.13.4 Pinyons Medical Technology Contrast Agent Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Covidien

      • 11.14.1 Covidien Company Details

      • 11.14.2 Covidien Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Covidien Contrast Agent Main Business and Markets Served

      • 11.14.4 Covidien Contrast Agent Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Mallinckrodt Pharmaceuticals

      • 11.15.1 Mallinckrodt Pharmaceuticals Company Details

      • 11.15.2 Mallinckrodt Pharmaceuticals Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Mallinckrodt Pharmaceuticals Contrast Agent Main Business and Markets Served

      • 11.15.4 Mallinckrodt Pharmaceuticals Contrast Agent Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 GE Healthcare

      • 11.16.1 GE Healthcare Company Details

      • 11.16.2 GE Healthcare Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 GE Healthcare Contrast Agent Main Business and Markets Served

      • 11.16.4 GE Healthcare Contrast Agent Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    12 Global Contrast Agent Market Outlook by Types and Applications to 2028

    • 12.1 Global Contrast Agent Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Gadolinium-Based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Barium-Based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Contrast Agent Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Interventional Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Radiology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Interventional Radiology Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Contrast Agent Market Analysis and Outlook to 2028

    • 13.1 Global Contrast Agent Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Contrast Agent Consumption Forecast (2022-2028)

      • 13.2.2 Canada Contrast Agent Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Contrast Agent Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.2 UK Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.3 Spain Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.5 France Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.6 Italy Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.8 Finland Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.9 Norway Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.11 Poland Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.12 Russia Contrast Agent Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Contrast Agent Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.2 Japan Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.3 India Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Contrast Agent Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Contrast Agent Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Contrast Agent Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Contrast Agent Consumption Forecast (2022-2028)

      • 13.5.3 Chile Contrast Agent Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Contrast Agent Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Contrast Agent Consumption Forecast (2022-2028)

      • 13.5.6 Peru Contrast Agent Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Contrast Agent Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Contrast Agent Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Contrast Agent Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Contrast Agent Consumption Forecast (2022-2028)

      • 13.6.3 Oman Contrast Agent Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Contrast Agent Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Contrast Agent Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Contrast Agent Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Contrast Agent Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Contrast Agent Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Contrast Agent Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Contrast Agent Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Contrast Agent Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Contrast Agent Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Contrast Agent

    • Figure of Contrast Agent Picture

    • Table Global Contrast Agent Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Contrast Agent Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Gadolinium-Based Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Barium-Based Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Interventional Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Radiology Consumption and Growth Rate (2017-2022)

    • Figure Global Interventional Radiology Consumption and Growth Rate (2017-2022)

    • Figure Global Contrast Agent Consumption by Country (2017-2022)

    • Table North America Contrast Agent Consumption by Country (2017-2022)

    • Figure United States Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Canada Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Mexico Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table Europe Contrast Agent Consumption by Country (2017-2022)

    • Figure Germany Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure UK Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Spain Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Belgium Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure France Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Italy Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Denmark Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Finland Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Norway Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Sweden Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Poland Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Russia Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Turkey Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table APAC Contrast Agent Consumption by Country (2017-2022)

    • Figure China Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Japan Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure India Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure South Korea Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Thailand Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Singapore Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Philippines Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table South America Contrast Agent Consumption by Country (2017-2022)

    • Figure Brazil Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Colombia Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Chile Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Argentina Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Peru Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table GCC Contrast Agent Consumption by Country (2017-2022)

    • Figure Bahrain Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Oman Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Qatar Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table Africa Contrast Agent Consumption by Country (2017-2022)

    • Figure Nigeria Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure South Africa Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Egypt Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Algeria Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table Oceania Contrast Agent Consumption by Country (2017-2022)

    • Figure Australia Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table Beekley Medical Company Details

    • Table Beekley Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beekley Medical Contrast Agent Main Business and Markets Served

    • Table Beekley Medical Contrast Agent Product Portfolio

    • Table ACIST Medical Systems Company Details

    • Table ACIST Medical Systems Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table ACIST Medical Systems Contrast Agent Main Business and Markets Served

    • Table ACIST Medical Systems Contrast Agent Product Portfolio

    • Table Medrad Company Details

    • Table Medrad Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medrad Contrast Agent Main Business and Markets Served

    • Table Medrad Contrast Agent Product Portfolio

    • Table AMAG Pharmaceuticals Company Details

    • Table AMAG Pharmaceuticals Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table AMAG Pharmaceuticals Contrast Agent Main Business and Markets Served

    • Table AMAG Pharmaceuticals Contrast Agent Product Portfolio

    • Table Bayer Healthcare Pharmaceuticals Company Details

    • Table Bayer Healthcare Pharmaceuticals Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Pharmaceuticals Contrast Agent Main Business and Markets Served

    • Table Bayer Healthcare Pharmaceuticals Contrast Agent Product Portfolio

    • Table Nova Biomedical Company Details

    • Table Nova Biomedical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nova Biomedical Contrast Agent Main Business and Markets Served

    • Table Nova Biomedical Contrast Agent Product Portfolio

    • Table Guerbet Company Details

    • Table Guerbet Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guerbet Contrast Agent Main Business and Markets Served

    • Table Guerbet Contrast Agent Product Portfolio

    • Table Bracco Diagnostic Company Details

    • Table Bracco Diagnostic Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Diagnostic Contrast Agent Main Business and Markets Served

    • Table Bracco Diagnostic Contrast Agent Product Portfolio

    • Table Lantheus Medical Company Details

    • Table Lantheus Medical Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Contrast Agent Main Business and Markets Served

    • Table Lantheus Medical Contrast Agent Product Portfolio

    • Table NycomedAmersham Company Details

    • Table NycomedAmersham Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table NycomedAmersham Contrast Agent Main Business and Markets Served

    • Table NycomedAmersham Contrast Agent Product Portfolio

    • Table Targeson Company Details

    • Table Targeson Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Targeson Contrast Agent Main Business and Markets Served

    • Table Targeson Contrast Agent Product Portfolio

    • Table Daiichi Company Details

    • Table Daiichi Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Contrast Agent Main Business and Markets Served

    • Table Daiichi Contrast Agent Product Portfolio

    • Table Pinyons Medical Technology Company Details

    • Table Pinyons Medical Technology Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pinyons Medical Technology Contrast Agent Main Business and Markets Served

    • Table Pinyons Medical Technology Contrast Agent Product Portfolio

    • Table Covidien Company Details

    • Table Covidien Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Covidien Contrast Agent Main Business and Markets Served

    • Table Covidien Contrast Agent Product Portfolio

    • Table Mallinckrodt Pharmaceuticals Company Details

    • Table Mallinckrodt Pharmaceuticals Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Pharmaceuticals Contrast Agent Main Business and Markets Served

    • Table Mallinckrodt Pharmaceuticals Contrast Agent Product Portfolio

    • Table GE Healthcare Company Details

    • Table GE Healthcare Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Contrast Agent Main Business and Markets Served

    • Table GE Healthcare Contrast Agent Product Portfolio

    • Figure Global Gadolinium-Based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Barium-Based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interventional Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interventional Radiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contrast Agent Consumption Forecast by Country (2022-2028)

    • Table North America Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure United States Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure Germany Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure China Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure Brazil Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure Australia Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.